Literature DB >> 28935348

Outcomes After Sleeve Lung Resections Versus Pneumonectomy in the United States.

Zaid M Abdelsattar1, K Robert Shen1, Sai Yendamuri2, Stephen Cassivi1, Francis C Nichols1, Dennis A Wigle1, Mark S Allen1, Shanda H Blackmon3.   

Abstract

BACKGROUND: The current national trends, practice patterns, and outcomes after sleeve resection compared with pneumonectomy in the United States are not known. In addition, whether hospital sleeve-to-pneumonectomy (S:P) ratios are a valid marker of hospital quality is unclear. We describe practice patterns and evaluate the utility of the S:P ratio.
METHODS: We identified all patients (N = 23,964) undergoing sleeve resection (n = 1,713) or pneumonectomy (n = 22,251) in the National Cancer Data Base between 1998 and 2012 at 644 hospitals. We used propensity score matching to compare short-term outcomes and overall survival between pneumonectomy and sleeve resection. We grouped hospitals into S:P ratio quintiles and used multilevel modeling to analyze hospital-level outcomes.
RESULTS: There has been a 1% yearly increase in sleeve resection rates, with wide variation in hospital S:P ratios (middle quintile, 1:12; range, 1:38 to 1:3). After propensity score matching, differences in age, clinical T and N stage, and the incidence of main bronchus tumors were negligible among other variables. Sleeve resections were associated with lower 30-day (1.6% vs 5.9%; p < 0.001) and 90-day mortality (4% vs 9.4%; p < 0.001) and improved overall survival. Hospitals with higher S:P ratios were not associated with better risk-adjusted 30-day (7.2% vs 7.4%; p = 0.244) or 90-day mortality (11.9% vs 12.2%; p = 0.308) or same-hospital readmission rates (3.7% vs 4.3%; p = 0.523).
CONCLUSIONS: Compared with pneumonectomy, sleeve resections are associated with improved short-term outcomes and improved overall survival. However, hospital S:P ratios were not associated with better risk-adjusted outcomes and thus may not be a valid quality measure.
Copyright © 2017 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2017        PMID: 28935348     DOI: 10.1016/j.athoracsur.2017.05.086

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  8 in total

1.  Extended sleeve lobectomy: its place in surgical therapy for centrally located non-small cell lung cancer and a review of technical aspects.

Authors:  Ryuichi Waseda; Akinori Iwasaki
Journal:  J Thorac Dis       Date:  2018-09       Impact factor: 2.895

2.  Surgical Techniques of Y-Sleeve Lobectomy in Patients With Primary Lung Cancer.

Authors:  Takuma Tsukioka; Nobuhiro Izumi; Hiroaki Komatsu; Hidetoshi Inoue; Ryuichi Ito; Noritoshi Nishiyama
Journal:  In Vivo       Date:  2022 Jan-Feb       Impact factor: 2.155

3.  Sleeve lobectomy and pneumonectomy: can they really be properly compared?

Authors:  Ramón Rami-Porta; Sergi Call
Journal:  Transl Lung Cancer Res       Date:  2020-06

4.  Time-varying analysis of readmission and mortality during the first year after pneumonectomy.

Authors:  Gregory D Jones; Kay See Tan; Raul Caso; Joseph Dycoco; Bernard J Park; Matthew J Bott; Daniela Molena; James Huang; James M Isbell; Manjit S Bains; David R Jones; Gaetano Rocco
Journal:  J Thorac Cardiovasc Surg       Date:  2020-03-07       Impact factor: 5.209

5.  Sleeve lobectomy compared with pneumonectomy for operable centrally located non-small cell lung cancer: a meta-analysis.

Authors:  Zhengjun Li; Wei Chen; Mozhu Xia; Hongxu Liu; Yongyu Liu; Ilhan Inci; Fabio Davoli; Ryuichi Waseda; Pier Luigi Filosso; Abby White
Journal:  Transl Lung Cancer Res       Date:  2019-12

6.  Propensity-matched Analysis Demonstrates Long-term Risk of Respiratory and Cardiac Mortality After Pneumonectomy Compared With Lobectomy for Lung Cancer.

Authors:  Gregory D Jones; Raul Caso; Kay See Tan; Joseph Dycoco; Prasad S Adusumilli; Manjit S Bains; Robert J Downey; James Huang; James M Isbell; Daniela Molena; Bernard J Park; Gaetano Rocco; Valerie W Rusch; Smita Sihag; David R Jones; Matthew J Bott
Journal:  Ann Surg       Date:  2022-04-01       Impact factor: 13.787

7.  Robotic sleeve resection for pulmonary disease.

Authors:  Chengqiang Li; Bin Zhou; Yu Han; Runsen Jin; Jie Xiang; Hecheng Li
Journal:  World J Surg Oncol       Date:  2018-04-02       Impact factor: 2.754

8.  Hybrid video-assisted thoracoscopic surgery sleeve lobectomy for non-small cell lung cancer: a case report.

Authors:  Chenlei Zhang; Zhanwu Yu; Jijia Li; Peng Zu; Pingwen Yu; Gebang Wang; Takuro Miyazaki; Ryuichi Waseda; Raul Caso; Giulio Maurizi; Hongxu Liu
Journal:  J Thorac Dis       Date:  2020-11       Impact factor: 3.005

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.